Investor Relations Home - Achieve Life Sciences

Investors Home

Home 2017-06-16T21:39:52+00:00

Investors Home

Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.

Click here to access our latest corporate presentation.

 

Stock Info

Recent Press Releases

Recent News
Nov 23, 2021

SEATTLE, Wash and VANCOUVER, British Columbia, November 23, 2021 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...

Nov 22, 2021

Following the fifth and final DSMC review, committee has concluded no concerns with cytisinicline safety or Phase 3 trial conduct SEATTLE, Wash and VANCOUVER, British Columbia, November 22, 2021...

Nov 9, 2021

SEATTLE, Wash and VANCOUVER, British Columbia, November 9, 2021 -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...